The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 05, 2017
Filed:
Feb. 12, 2015
Applicant:
Portola Pharmaceuticals, Inc., South San Francisco, CA (US);
Inventors:
Qing Xu, Foster City, CA (US);
Yonghong Song, Foster City, CA (US);
Anjali Pandey, Fremont, CA (US);
Assignee:
Portola Pharmaceuticals, Inc., South San Francisco, CA (US);
Primary Examiner:
Int. Cl.
CPC ...
C07D 417/12 (2006.01); C07D 237/24 (2006.01); C07D 409/12 (2006.01); C07D 401/12 (2006.01); C07D 403/12 (2006.01); C07D 401/14 (2006.01); C07D 403/14 (2006.01); C07D 409/14 (2006.01); C07D 405/14 (2006.01);
U.S. Cl.
CPC ...
C07D 417/12 (2013.01); C07D 237/24 (2013.01); C07D 401/12 (2013.01); C07D 401/14 (2013.01); C07D 403/12 (2013.01); C07D 403/14 (2013.01); C07D 405/14 (2013.01); C07D 409/12 (2013.01); C07D 409/14 (2013.01);
Abstract
In one aspect, the invention provides a compound according to formula I, as well as tautomers, pharmaceutically acceptable salts, and hydrates thereof. Pharmaceutical compositions, methods of inhibiting Janus kinases (JAKs), and methods for treating a condition or disorder mediated at least in part by JAK kinase activity are also described.